Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma.

Autor: Heinzerling, Lucie M., Urbanek, Margarete, Funk, Jens O., Peker, Stefan, Bleck, Oliver, Neuber, Karsten, Burg, Günter, von den Driesch, Peter, Dummer, Reinhard
Zdroj: Cancer (0008543X); Oct2000, Vol. 89 Issue 8, p1835-1844, 10p
Databáze: Complementary Index
Externí odkaz: